Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006-2011)

BMC Infectious Diseases

José María Amate-Blanco¹  Zuleika Saz-Parkinson¹  Teresa López-Cuadrado¹  Carmen Bouza¹ 

[1] Health-Care Technology Assessment Agency, National Center of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain

关键词: Trends;    Mortality;    Incidence;    Health services research;    General population;    Epidemiology;    Severe sepsis;   

Others  :  1125361
DOI  :  10.1186/s12879-014-0717-7

 received in 2014-10-24, accepted in 2014-12-15,  发布年份 2014

【 摘 要 】

Background

Although severe sepsis constitutes an important burden for healthcare systems, there is limited nationwide data on its epidemiology in European countries. Our objective was to examine the most recent epidemiological characteristics and trends of severe sepsis in Spain, from a population perspective.

Methods

Analysis of the 2006-2011 National Hospital Discharge Registry. Cases were identified by combining specific ICD-9CM codes. We estimated demographics, clinical characteristics and outcomes and calculated age- and sex- adjusted estimations of incidence and mortality rates. Trends were assessed in terms of annual percent change (APC) in rates using joinpoint regression analysis.

Results

Over the 6-year period we identified 240939 cases of severe sepsis nationwide representing 1.1% of all hospitalisations and 54% of hospitalisations with sepsis. Incidence was 87 cases per 100,000 population. Overall 58% of cases were men, 66% were over the age of 65 and about 67% had associated comorbidities. Bacteremia was coded in 16% of records. Almost 54% of cases had one organ dysfunction, 26% two and around 20% three or more dysfunctions. In-hospital case-fatality was 43% and associated with age, gender, comorbidities and organ dysfunctions, among others. We found significant demographic and clinical changes over time with an increase in the mean age of cases, comorbidities, number of organ dysfunctions and in the number of cases with gram-negative pathogens. Furthermore, even with gender disparities, standardised incidence and mortality rates increased with an overall APC of 8.6% (95% CI 5.1, 12.1) and 6% (95% CI 1.9, 10.3), respectively. Conversely, we detect a significant decrease in case-fatality rates with an overall APC of -3.24% (95% CI: -4.2, -2.2).

Conclusions

This nationwide population-based study shows that hospitalizations with severe sepsis are frequent and associated with substantial in-hospital mortality in Spain. Furthermore it indicates that the incidence and mortality rates of severe sepsis have notably increased in recent years, showing also a significant increase in the age and severity of the affected population. Despite this, there has been a significant decreasing trend in case-fatality rates over time. This information has significant implications for health-care system planning and may prove useful to estimate future care requirements.

【 授权许可】

   
2015 Bouza et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013, 369:840-851.
• [2]Martin GS: Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcome. Expert Rev Anti Infect Ther 2012, 10:701-706.
• [3]Iwashyna TJ, Ely EW, Smith DM, Langa KM: Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010, 314:1787-1794.
• [4]Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
• [5]Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
• [6]Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med 2005, 33:2555-2562.
• [7]Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250.
• [8]Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK: Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012, 40:754-761.
• [9]Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A: Inpatient care for septicaemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief 2011, 62:1-8.
• [10]Angus DC: The lingering consequences of sepsis: a hidden public health disaster? JAMA 2010, 304:1833-1834.
• [11]Flatten H: Epidemiology of sepsis in Norway in 1999. Crit Care 2004, 8:R180-R184. BioMed Central Full Text
• [12]Iñigo J, Sendra JM, Diaz R, Bouza C, Sarría-Santamera A: Epidemiología y costes de la sepsis grave en Madrid. Estudio de altas hospitalarias. Med Intensiva 2006, 30:197-203.
• [13]Andreu Ballester JC, Ballester F, González Sánchez A, Almela Quilis A, Colomer Rubio E, Peñarroja Otero C: Epidemiology of sepsis in the Valencian Community (Spain), 1995-2004 . Infect Control Hosp Epidemiol 2008, 29:630-634.
• [14]Sundararajan V, Macisaac CM, Presneill JJ, Cade JF, Visvanathan K: Epidemiology of sepsis in Victoria, Australia. Crit Care Med 2005, 33:71-80.
• [15]Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, Honrubia T, Algora A, Bustos A, Garcia G, Diaz-Regañon IR, de Luna RR: Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007, 35:1284-1289.
• [16]Rubenfeld GD, Angus DC, Pinsky MR, Curtis JR, Connors AF Jr, Bernard GR: Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. Am J Respir Crit Care Med 1999, 160:358-367.
• [17]Lawrenson R, Williams T, Farmer R: Clinical information for research: the use of general practice databases. J Public Health Med 1999, 21:299-304.
• [18]Gaieski DF, Edwards JM, Kallan MJ, Carr BG: Benchmarking the incidence and mortality of severe sepsis in United States. Crit Care Med 2013, 41:1167-1174.
• [19]Sistema de Información Sanitaria Servicio Nacional de Salud. Ministerio de Sanidad. [http://www.msssi.gob.es/estadEstudios/estadisticas/sisInfSanSNS/tablasEstadisticas/home.htm]
• [20]Instituto Nacional de Estadística. [http://www.ine.es/]
• [21]Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619.
• [22]Librero J, Peiró S, Ordiñana R: Chronic comorbidity and outcomes of hospital care: length of stay, mortality and readmission at 30 and 365 days. J Clin Epidemiol 1999, 52:171-179.
• [23]Law14/2007, of 3 July, on Biomedical Research. [www.boe.es]
• [24]Eurostat. Revision of the European Standard Population Report of Eurostat’s task force. 2013 edition; Luxembourg: European Commission [http://epp.eurostat.ec.europa.eu].
• [25]Joinpoint Regression Program. Version 3.5.1. July 2011; Statistical Methodology and Applications Branch and Data Modeling Branch, Surveillance Research Program National Cancer Institute. US.gov [http://www.srab.cancer.gov.joinpoint]
• [26]Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK: Estimating average annual percent change in trend analysis. Stat Med 2009, 28:3670-3678.
• [27]Kim HJ, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000, 19:335-351.
• [28]Ayala-Ramírez OH, Domínguez-Berjón MF, Esteban-Vasallo MD: Trends in hospitalizations of patients with sepsis and factors associated with inpatient mortality in the Region of Madrid, 2003-2011. Eur J Clin Microbiol Infect Dis 2014, 33:411-421.
• [29]Wilhelms SB, Huss FR, Granath G, Sjöberg F: Assessment of incidence of severe sepsis in Sweden using different ways of abstracting International Classification of Diseases codes: difficulties with methods and interpretation of results. Crit Care Med 2010, 38:1442-1449.
• [30]Milbrandt EB, Eldadah B, Nayfield S, Hadley E, Angus DC: Toward an integrated research agenda for critical illness in aging. Am J Respir Crit Care Med 2010, 182:995-1003.
• [31]Martin GS, Mannino DM, Moss M: The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006, 34:15-21.
• [32]Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS: The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med 2006, 34:2576-2582.
• [33]Whittaker SA, Mikkelsen ME, Gaieski DF, Koshy S, Kean C, Fuchs BD: Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population. Crit Care Med 2013, 41:945-953.
• [34]Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, et al.: Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008, 12:R158. doi:10.1186/cc7157 BioMed Central Full Text
• [35]Dreiher J, Almog Y, Sprung CL, Codish S, Klein M, Einav S, et al.: Temporal trends in patient characteristics and survival of intensive care admissions with sepsis: a multicenter analysis. Crit Care Med 2012, 40:855-860.
• [36]Ferrer R, Artigas A, Levy MM, Blanco J, González-Díaz G, Garnacho-Montero J, et al.: Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
• [37]Angus DC, Burgner D, Wunderink R, Mira JP, Gerlach H, Wiedermann CJ, et al.: The PIRO concept: P is for predisposition. Crit Care 2003, 7:248-251. BioMed Central Full Text
• [38]Adrie C, Azoulay E, Francais A, Clec’h C, Darques L, Schwebel C, et al.: Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 2007, 132:1786-1793.
• [39]von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al.: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007, 335:806-808.
• [40]Ley Orgánica 15/1999 de 13 de Diciembre de Protección de Datos de Carácter personal. Boletín Oficial del Estado. [www.boe.es/buscar/doc.php?id=BOE-A-1999-23750]
• [41]Ley 41/2002, de 14 noviembre, ley básica reguladora de la autonomía del paciente y de derechos y obligaciones en materia de información y documentación clínica. Boletín Oficial del Estadon°274, de 15-11-2002. [www.msssi.gob.es]
• [42]Linde-Zwirble WT, Angus DC: Severe sepsis epidemiology: sampling, selection, and society. Crit Care 2004, 8:222-226. BioMed Central Full Text
• [43]Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ: Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med 2014, 42:625-631.
• [44]Wilchesky M, Tamblyn RM, Huang A: Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004, 57:131-141.
• [45]McPherson D, Griffiths C, Williams M, Baker A, Klodawski E, Jacobson B, et al.: Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ Open. 2013, 3:e002586. doi:10.1136/bmjopen-2013-002586